Ig replacement therapy ‘beneficial’ for patients with blood cancers
![](https://www.ausdoc.com.au/wp-content/uploads/2023/08/4x3_Blood20iStock-1257429592-1-300x225.jpg)
Immunoglobulin replacement therapy is associated with reductions in hypogammaglobulinaemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukaemia or non-Hodgkin’s lymphoma, according to a study in Blood Advances.
Dr Jacob D Soumerai, from the Massachusetts General Hospital Cancer Center in Boston, and colleagues examined patterns of immunoglobulin G (IgG) testing and the effectiveness of immunoglobulin replacement therapy in patients with chronic lymphocytic leukaemia (CLL) or non-Hodgkin’s lymphoma (NHL) in a retrospective, longitudinal study.